Chemical Conjugation Of Evans Blue Derivative Prolongs Blood Half-life And Improves The Integrin alpha(V)beta(3)-targeted (177)lu-radionuclide Therapy In A Patient-derived Xenograft Model Of Lung Adenocarcinoma
机构：[1]The First Affiliated Hospital of Xiamen University, Xiamen, CHINA,[2]Beijing Tiantan Hospital, Beijing, CHINA,首都医科大学附属天坛医院[3]Center for Molecular Imaging and Translational Med, Xiamen, CHINA,[4]9000 Rockville Pike, Bethesda, MD, UNITED STATES OF AMERICA,[5]NIBIB/NIH, Bethesda, MD, UNITED STATES OF AMERICA
第一作者机构：[1]The First Affiliated Hospital of Xiamen University, Xiamen, CHINA,
推荐引用方式(GB/T 7714)：
Zhao L.,Chen H.,Fu K.,et al.Chemical Conjugation Of Evans Blue Derivative Prolongs Blood Half-life And Improves The Integrin alpha(V)beta(3)-targeted (177)lu-radionuclide Therapy In A Patient-derived Xenograft Model Of Lung Adenocarcinoma[J].EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING.2019,46(SUPPL 1):S285-S286.
APA：
Zhao, L.,Chen, H.,Fu, K.,Fan, D.,Guo, Z....&Chen, X..(2019).Chemical Conjugation Of Evans Blue Derivative Prolongs Blood Half-life And Improves The Integrin alpha(V)beta(3)-targeted (177)lu-radionuclide Therapy In A Patient-derived Xenograft Model Of Lung Adenocarcinoma.EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING,46,(SUPPL 1)
MLA：
Zhao, L.,et al."Chemical Conjugation Of Evans Blue Derivative Prolongs Blood Half-life And Improves The Integrin alpha(V)beta(3)-targeted (177)lu-radionuclide Therapy In A Patient-derived Xenograft Model Of Lung Adenocarcinoma".EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 46..SUPPL 1(2019):S285-S286
医学